2.36
0.43%
0.010
Neurobo Pharmaceuticals Inc (NRBO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
20.74%
0.237
|
0.299 | 0.162 | - | - |
Operating Expenses |
19.31%
7.118
|
5.966 | 4.055 | - | - |
Benefits Costs and Expenses |
23.84%
6.951
|
5.613 | 3.98 | - | - |
Costs And Expenses |
21.42%
6.881
|
5.667 | 3.893 | 3.806 | 2.52 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
21.42%
-6.881
|
-5.667 | -3.893 | -3.806 | -2.52 |
Net Interest Income/Expense |
20.74%
0.237
|
0.299 | 0.162 | - | - |
Interest Income/Expense After Provision For Losses |
20.74%
0.237
|
0.299 | 0.162 | - | - |
Income/Loss From Continuing Operations Before Tax |
26.35%
-6.714
|
-5.314 | -3.818 | -0.734 | -2.604 |
Income Tax Expense/Benefit |
100.00%
-
|
-3.248 | - | - | - |
Income/Loss From Continuing Operations After Tax |
224.98%
-6.714
|
-2.066 | -3.818 | -0.734 | -2.604 |
Net Income/Loss
|
26.35%
-6.714
|
-5.314 | -3.818 | -0.734 | -2.604 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
114.36%
5.0894
|
-35.45 | 40.61 | 40.47 | 40.47 |
Diluted Average Shares |
114.36%
5.0894
|
-35.45 | 40.61 | 40.47 | 40.47 |
Basic Earnings Per Share |
42.11%
-1.32
|
-2.28 | -0.09 | -0.02 | -0.06 |
Diluted Earnings Per Share |
42.11%
-1.32
|
-2.28 | -0.09 | -0.02 | -0.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):